Two of these, CD32B+ and CD36+ cDC2s (also referred to by others as CD1C_A/DC2 and CD1C_B/DC3, respectively), were previously identified in peripheral blood (24), the former of which we found to be substantially elevated in the CSF of subjects with MS. Here, FCGR2B is linked to myeloid sarcoma.